Trial Profile
Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in HBeAg-positive and HBeAg-negative Chronic Hepatitis B
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Oct 2023
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms HBRN IA Adult; HBRN Immune Active
- 07 Oct 2023 Results assessing patient-reported liver symptoms during treatment for chronic hepatitis B viral (HBV) infection and associations between changes in symptoms and levels of alanine aminotransferase (ALT) and viral markers, published in the Digestive Diseases and Sciences.
- 01 Jul 2023 Results published in the American Journal of Gastroenterology
- 25 Apr 2023 Status changed from active, no longer recruiting to completed.